3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Carcinoma, Non-Small-Cell Lung
6
Rectal Neoplasms
5
Colonic Neoplasms
5
Neoplasms
4
Neoplasm Metastasis
4
Lung Neoplasms
4
Brain Neoplasms
4
Ovarian Neoplasms
3
Melanoma
3
Glioblastoma
3
Breast Neoplasms
3
Advanced Solid Tumor
3
Stomach Neoplasms
2
Pancreatic Neoplasms
2
Oligodendroglioma
2
Gliosarcoma
2
Colorectal Neoplasms
2
Carcinoma, Renal Cell
2
Breast Neoplasms, Male
2
Astrocytoma
2
Waldenstrom Macroglobulinemia
1
Uterine Cervical Neoplasms
1
Spinal Cord Neoplasms
1
Sezary Syndrome
1
Rhabdoid Tumor
1
Recurrence
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Optic Nerve Glioma
1
Neoplasms, Plasma Cell
1
Interventions
cediranib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Advanced Prostate Adenocarcinoma
×
cediranib
×
Clear all
NCT00502164
2011-01-21
AZD2171IL/0003
AstraZeneca
Phase 1
Completed
40 enrolled